How can the business benefit of Business Continuity Planning be measured? -A case study at AstraZeneca
(2006) In LUTVDG/TVBB--5212--SE VBR920Division of Fire Safety Engineering
Risk Management and Safety Engineering (M.Sc.Eng.)
Division of Risk Management and Societal Safety
- Abstract
- This thesis treats the area of Business Continuity Planning (BCP), which is one way to decrease the vulnerability in an organization. The main objective was to investigate how the business benefit of BCP could be measured in monetary terms. The aim of this investigation was the development of a general and practically usable framework. The framework was developed in a deductive way by combining theory about BCP, risk, decision making, and investment valuation. The framework is a five step work process that results in a ranking of the risk reducing investments based on their calculated Risk Adjusted Net Present Value (RANPV). The BCP process generates risk reducing investment alternatives that can be valuated with the framework. The thesis... (More)
- This thesis treats the area of Business Continuity Planning (BCP), which is one way to decrease the vulnerability in an organization. The main objective was to investigate how the business benefit of BCP could be measured in monetary terms. The aim of this investigation was the development of a general and practically usable framework. The framework was developed in a deductive way by combining theory about BCP, risk, decision making, and investment valuation. The framework is a five step work process that results in a ranking of the risk reducing investments based on their calculated Risk Adjusted Net Present Value (RANPV). The BCP process generates risk reducing investment alternatives that can be valuated with the framework. The thesis has been performed in cooperation with AstraZeneca where a case study was carried out to test the practical usability of the framework. This thesis showed that the developed framework is general, practically usable and can measure the business benefit of BCP in monetary terms if the requirements of the user of the framework are met. (Less)
Please use this url to cite or link to this publication:
http://lup.lub.lu.se/student-papers/record/1688970
- author
- Degerfalk, Lisa and Larsson, Mattias
- supervisor
- organization
- course
- VBR920
- year
- 2006
- type
- H2 - Master's Degree (Two Years)
- subject
- keywords
- AstraZeneca, Business Continuity Planning (BCP), Business benefit, Decision making, Net Present Value (NPV), Risk Adjusted Net Present Values (RANPV), Risk reducing investment alternative
- publication/series
- LUTVDG/TVBB--5212--SE
- report number
- 5212
- ISSN
- 1402-3504
- language
- English
- id
- 1688970
- date added to LUP
- 2011-01-20 17:00:32
- date last changed
- 2020-12-03 14:26:05
@misc{1688970, abstract = {{This thesis treats the area of Business Continuity Planning (BCP), which is one way to decrease the vulnerability in an organization. The main objective was to investigate how the business benefit of BCP could be measured in monetary terms. The aim of this investigation was the development of a general and practically usable framework. The framework was developed in a deductive way by combining theory about BCP, risk, decision making, and investment valuation. The framework is a five step work process that results in a ranking of the risk reducing investments based on their calculated Risk Adjusted Net Present Value (RANPV). The BCP process generates risk reducing investment alternatives that can be valuated with the framework. The thesis has been performed in cooperation with AstraZeneca where a case study was carried out to test the practical usability of the framework. This thesis showed that the developed framework is general, practically usable and can measure the business benefit of BCP in monetary terms if the requirements of the user of the framework are met.}}, author = {{Degerfalk, Lisa and Larsson, Mattias}}, issn = {{1402-3504}}, language = {{eng}}, note = {{Student Paper}}, series = {{LUTVDG/TVBB--5212--SE}}, title = {{How can the business benefit of Business Continuity Planning be measured? -A case study at AstraZeneca}}, year = {{2006}}, }